Onderzoek naar de economische waarde van nieuwe longkanker- en ILD-geneesmiddelen.
The aim is to present current and new strategies university hospitals can undertake to contain costs of expensive drugs using a drug life cycle approach.
To describe the impact of COVID-19 on the continuity of care in the primary care setting.
To describe the impact of delirium and frailty on clinical outcomes in COVID-19 patients admitted to the hospital.
To describe the impact of delirium on recovery of COVID-19 patients in geriatric rehabilitation.
To describe perceptions, motivations, needs and experiences of geriatricians with scientific research.
To explore and implement strategies for optimizing healthcare resource utilization in oncology, with the aim of advancing the (financial) sustainability in oncology care.
My research focuses on the socioeconomic determinants of psychotropic medication use in children and adolescents. Specifically, I aim to identify the complex relationships between socioeconomic factors and psychotropic medication use in young people, and to explore potential avenues for improving health outcomes in this vulnerable population.
Hospital expenditure of expensive drugs increases yearly. In addition, shortages are becoming more common. To assure access to healthcare and treatment in the future, sustainable use of expensive drugs is very important. This research aims to optimize treatment with regard to efficacy and safety, while aiming to reduce drug costs.